ENDRA Life Sciences (NASDAQ:NDRA) Trading Down 0.3% – What’s Next?

ENDRA Life Sciences Inc. (NASDAQ:NDRAGet Free Report) was down 0.3% during mid-day trading on Friday . The company traded as low as $5.81 and last traded at $5.98. Approximately 27,030 shares were traded during trading, a decline of 18% from the average daily volume of 33,069 shares. The stock had previously closed at $6.00.

ENDRA Life Sciences Trading Down 0.3 %

The firm has a market capitalization of $3.21 million, a PE ratio of -0.01 and a beta of 0.52. The business has a 50-day moving average of $5.74 and a 200 day moving average of $1,963.01.

About ENDRA Life Sciences

(Get Free Report)

ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.

Further Reading

Receive News & Ratings for ENDRA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ENDRA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.